Letter: vaccination for global control of hepatitis B-from prevention to elimination
- PMID: 36352745
- DOI: 10.1111/apt.17213
Letter: vaccination for global control of hepatitis B-from prevention to elimination
Comment in
-
Letter: vaccination for global control of hepatitis B-from prevention to elimination. Authors' reply.Aliment Pharmacol Ther. 2022 Dec;56(11-12):1629-1630. doi: 10.1111/apt.17271. Aliment Pharmacol Ther. 2022. PMID: 36352750 No abstract available.
Comment on
-
Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma.Aliment Pharmacol Ther. 2022 Sep;56(5):869-877. doi: 10.1111/apt.17120. Epub 2022 Jul 21. Aliment Pharmacol Ther. 2022. PMID: 35864571
References
REFERENCES
-
- Wong GL, Hui VW, Yip TC, Liang LY, Zhang X, Tse YK, et al. Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma. Aliment Pharmacol Ther. 2022;56:869-877.
-
- Thomas DL. Global elimination of chronic hepatitis. N Engl J Med. 2019;23(380):2041-50.
-
- Lin CL, Kao JH. Hepatitis B: immunization and impact on natural history and cancer incidence. Gastroenterol Clin North Am. 2020;49:201-14.
-
- Chang KC, Chang MH, Chen HL, Wu JF, Chang CH, Hsu HY, et al. Universal infant hepatitis B virus (HBV) vaccination for 35 years: moving toward the eradication of HBV. J Infect Dis. 2022;225:431-5.
-
- Kao JH. Hepatitis B vaccination and prevention of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2015;29:907-17.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical